S100A8, S100A9 and S100A12 proteins in rheumatoid arthritis;Protéines S100A8, S100A9 et S100A12 : marqueurs inflammatoires ou acteurs physiopathologiques de la polyarthrite rhumatoïde

Revue de Medecine Interne

Volumn 31, Issue 6, 2010, Pages 458-461

  Baillet, A ^a  

^a Hopital Sud   (France)

Author keywords

Biomarkers; Inflammation; Rheumatoid arthritis; S100 proteins

Indexed keywords

CALGRANULIN A; PROTEIN S 100; PROTEIN S 100A12; PROTEIN S 100A9; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CALGRANULIN B; S100A12 PROTEIN, HUMAN;

AUTOIMMUNITY; DISEASE ACTIVITY; DISEASE ASSOCIATION; PATHOGENESIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PSEUDOTUMOR; RHEUMATOID ARTHRITIS; SHORT SURVEY; SYNOVIAL FLUID; SYNOVIUM; ARTHRITIS, RHEUMATOID; BLOOD; DISEASE COURSE; HUMAN; IMMUNOLOGY; INFLAMMATION; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CALGRANULIN A; CALGRANULIN B; DISEASE PROGRESSION; HUMANS; INFLAMMATION; PREDICTIVE VALUE OF TESTS; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 77953610648     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.10.435     Document Type: Short Survey

References (20)

1. Schellekens G.A., Visser H., de Jong B.A., van den Hoogen F.H., Hazes J.M., Breedveld F.C., et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000, 43:155-163.
2. Ryckman C., McColl S.R., Vandal K., de Medicis R., Lussier A., Poubelle P.E., et al. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum 2003, 48:2310-2320.
3. Foell D., Roth J. Proinflammatory S100 proteins in arthritis and autoimmune disease. Arthritis Rheum 2004, 50:3762-3771.
4. Baillet A, Trocmé C, Berthier S, Arlotto M, Grange L, Chenau J, et al. Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology 2010;49:671-82.
5. van Lent P.L., Grevers L., Blom A.B., Sloetjes A., Mort J.S., Vogl T., et al. Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis 2008, 67:1750-1758.
6. Hammer H.B., Odegard S., Syversen S.W., Landewe R., van der Heijde D., Uhlig T., et al. Calprotectin (a major S100 leukocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Ann Rheum Dis 2010, 69:150-154.
7. Wulffraat N.M., Haas P.J., Frosch M., De Kleer I.M., Vogl T., Brinkman D.M., et al. Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation. Ann Rheum Dis 2003, 62:236-241.
8. Berthier S., Paclet M.H., Lerouge S., Roux F., Vergnaud S., Coleman A.W., et al. Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation. J Biol Chem 2003, 278:25499-25508.
9. Berthier S, Baillet A, Paclet MH, Gaudin P, Morel F. How important are S100A8/S100A9 calcium binding proteins for the activation of phagocyte NADPH oxidase, Nox2. AIAAMC 2009;8:282-284.
10. Yong H.Y., Moon A. Roles of calcium-binding proteins. S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch Pharm Res 2007, 30:75-81.
11. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
12. Vogl T., Tenbrock K., Ludwig S., Leukert N., Ehrhardt C., van Zoelen M.A., et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007, 13:1042-1049.
13. Steenvoorden M.M., Toes R.E., Ronday H.K., Huizinga T.W., Degroot J. RAGE activation induces invasiveness of RA fibroblast-like synoviocytes in vitro. Clin Exp Rheumatol 2007, 25:740-742.
14. Hiratsuka S., Watanabe A., Aburatani H., Maru Y. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 2006, 8:1369-1375.
15. Altwegg L.A., Neidhart M., Hersberger M., Muller S., Eberli F.R., Corti R., et al. Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes. Eur Heart J 2007, 28:941-948.
16. de Seny D., Fillet M., Meuwis M.A., Geurts P., Lutteri L., Ribbens C., et al. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. Arthritis Rheum 2005, 52:3801-3812.
17. Liao H., Wu J., Kuhn E., Chin W., Chang B., Jones M.D., et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 2004, 50:3792-3803.
18. Hammer H.B., Odegard S., Fagerhol M.K., Landewe R., van der Heijde D., Uhlig T., et al. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis 2007, 66:1093-1097.
19. Foell D., Kane D., Bresnihan B., Vogl T., Nacken W., Sorg C., et al. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 2003, 42:1383-1389.
20. Foell D., Wittkowski H., Hammerschmidt I., Wulffraat N., Schmeling H., Frosch M., et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthritis Rheum 2004, 50:1286-1295.